What is Altis Labs?
Altis Labs specializes in AI-powered software designed to predict drug efficacy and patient outcomes through the analysis of medical imaging data, specifically CT scans. By providing biopharma sponsors and clinical sites with actionable insights, the company effectively reduces the uncertainty inherent in drug development. Their platform serves as a bridge between raw imaging data and clinical decision-making, enabling researchers to identify therapeutic signals that might otherwise remain obscured. This technological capability is essential for modernizing clinical trials, reducing costs, and ultimately accelerating the delivery of life-saving therapies to patients in need.
How much funding has Altis Labs raised?
Altis Labs has raised a total of $31M across 1 funding round:
Angel/Seed
$6M
Angel/Seed (2023): $6M with participation from BenchStrength International and Debiopharm
Key Investors in Altis Labs
BenchStrength International
BenchStrength International is a specialized consulting firm providing strategic and tactical guidance to insurance and risk management sectors, focusing on system integration and operational efficiency.
Debiopharm
Debiopharm Investment acts as the financial arm of the Debiopharm Group, managing private equity and capital allocations with a focus on long-term growth and strategic healthcare investments.
What's next for Altis Labs?
With this major enterprise-level funding, Altis Labs is poised to accelerate its product roadmap and deepen its integration with global clinical research networks. The company is expected to focus on enhancing its predictive algorithms and expanding its data processing capabilities to handle larger, more diverse datasets. By strengthening its strategic partnerships with biopharma leaders, Altis Labs aims to standardize the use of AI-driven imaging analytics in regulatory submissions and clinical trial design. The firm is well-positioned to capitalize on the increasing demand for precision medicine, ensuring that its technology becomes a cornerstone of future pharmaceutical innovation.
See full Altis Labs company page
